Company: LPSN
Filing Date: 2025-09-15
Form Type: DEFA14A
Source: 0001102993-25-000156
Chunk: 284

Company: LIVEPERSON INC
Filing Date: 2025-09-15
Form: DEFA14A
Chunk 284
---
___________________________ Name: Cynthia Paul Title: Member Execution Version Acknowledged and Agreed: LivePerson, Inc. By: _/s/ John Collins____________________ Name: John Collins Title: Chief Operating Officer and Chief Financial Officer Execution Version

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [*] INDICATES THAT INFORMATION HAS BEEN REDACTED. AMENDMENT NO. 1 TO EXCHANGE AGREEMENT This Amendment No. 1 (this “Amendment”) to the Exchange Agreement, dated as of August 11, 2025 (the “Agreement”), by and among LivePerson, Inc., a Delaware corporation, and each of the holders listed on Schedule A attached to the Agreement (collectively, the “Parties”), is made and entered into by the Parties as of September 11, 2025. Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement. RECITALS WHEREAS, pursuant to and in accordance with Section 5.10 of the Agreement, the Agreement may be amended from time to time with the written consent of the Parties; and WHEREAS, the Parties desire to amend the Agreement in the manner set forth below. AGREEMENT NOW, THEREFORE, in consideration of the mutual promises contained herein and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Agreement is hereby amended by the Parties in accordance with the terms of Section 5.10 of the Agreement as follows: 1. Amendments. (i) The fifth paragraph of the Recitals of the Agreement is hereby amended as follows (any bolded, double underlined text being added and any bolded, strikethrough text being deleted): WHEREAS, on the Closing Date, the Company shall issue no less than an aggregate 51,188,16553,333,947 Common Equity Shares to the Noteholders and the sum of the aggregate (i) Common Equity Shares plus (ii) the shares of Common Stock into which the Preferred Equity Shares are convertible (the “Conversion Shares”) will equal 39.0% of the fully-diluted outstanding Common Stock on the Closing Date (the “Aggregate Equity Amount”); for purposes of this Agreement, “fully-diluted” shall include the total number of shares of Common Stock outstanding on the Closing Date, assuming the full conversion